Johnson & Johnson (NYSE:JNJ)
| 148.96 Delayed Data As of 5:57pm ET |  +0.82 / +0.55%Today’s Change | 109.16 Today|||52-Week Range 157.00 | +2.12% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 148.14 |
| Today’s open | 148.19 |
| Day’s range | 147.69 - 149.57 |
| Volume | 7,306,062 |
| Average volume (3 months) | 6,452,463 |
| Market cap | $379.1B |
Data as of 5:57pm ET, 12/03/2020
Growth & Valuation
| Earnings growth (last year) | +0.28% |
| Earnings growth (this year) | -7.83% |
| Earnings growth (next 5 years) | +5.75% |
| Revenue growth (last year) | +0.71% |
| P/E ratio | 23.4 |
| Price/Sales | 4.76 |
| Price/Book | 6.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.90 | -2.21% |
| NVSNovartis | -1.30 | -1.42% |
| MRKMerck | -0.60 | -0.73% |
| ABBVAbbVie | -0.35 | -0.33% |
Data as of 5:04pm ET, 12/03/2020
Financials
| Next reporting date | January 26, 2021 |
| EPS forecast (this quarter) | $1.83 |
| Annual revenue (last year) | $82.1B |
| Annual profit (last year) | $15.1B |
| Net profit margin | 18.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
